2-Anilinotropone-Based Nickel(II) Catalysts
Organometallics, Vol. 22, No. 17, 2003 3543
δ 6.85 (at, H ) 10.2 Hz, 1 H), 6.73 (d, J ) 10 Hz, 1 H), 6.69 (at
J ) 11.4 Hz, 1 H), 6.19 (d, J ) 11.2 Hz, 1 H), 6.14 (at, J ) 9.2
Hz, 1 H).
Na Sa lt of 2-(2-Meth yla n ilin o)tr op on e (7j). The general
procedure was employed with 508 mg (2.4 mmol) of anilino-
tropone and 69 mg (2.9 mmol) of NaH. The salt was isolated
with 0.89 equiv of THF. 1H NMR (400 MHz, C6D6): δ 7.11 (m,
2 H), 6.93 (m, 1 H), 6.64-6.45 (m, 4 H), 6.41 (dd, J ) 8.6, 11.4
Hz, 1 H), 6.08 (at, J ) 9.0 Hz, 1 H), 3.46 (THF), 1.89 (s, 3 H),
1.32 (THF).
Na Sa lt of 2-(2-Met h yl-6-(t r iflu or om et h yl)a n ilin o)-
tr op on e (7k ). The general procedure was employed with 688
mg (2.5 mmol) of anilinotropone and 71 mg (2.95 mmol) of
NaH. The salt was isolated with 1 equiv of THF. 1H NMR (400
MHz, C6D6): δ 7.39 (d, J ) 7.6 Hz, 1 H), 7.06 (d, J ) 7.6 Hz,
1 H), 6.70 (at, J ) 7.6 Hz, 1 H), 6.57 (m, 2 H), 6.45 (dd, J )
8.2, 11.6 Hz, 1 H), 6.28 (d, J ) 11.6 Hz, 1 H), 6.08 (at, J ) 8.8
Hz, 1 H), 3.46 (THF), 1.88 (s, 3 H), 1.33 (THF).
to afford 195 mg (57%) of the desired complex as a yellow-
orange solid. 1H NMR (400 MHz, CD2Cl2): δ 7.47 (m, 6 H),
7.38 (m, 3 H), 7.28 (m, 6 H), 7.18 (dd, J ) 1.4, 8 Hz, 1 H), 7.11
(bs, 1 H), 6.95 (at, J ) 10.2 Hz, 1 H), 6.81 (m, 2 H), 6.72 (m,
1 H), 6.55 (M, 2 H), 6.46 (d, J ) 9.4 Hz, 1 H), 6.42 (dd, J )
1.6, 7.7 Hz, 1 H), 6.23 (m, 2 H), 6.07 (bs, 1 H), 1.51 (s, 9 H).
13C NMR (100 MHz, CD2Cl2): δ 179.9 (d, J ) 7.5 Hz), 169.1,
151.3 (d, J ) 45 Hz), 146.9, 142.3, 138.4 (broad), 137.8 (broad),
134.8, 134.6 (d, J ) 10.5 Hz), 133.7, 131.9, 131.5, 130.1 (d, J
) 1.9 Hz), 128.9, 128.8, 128.2 (d, J ) 9.7 Hz), 126.3, 125.1
(broad), 124.2, 121.6, 120.9, 120.7, 120.5, 36.4, 32.8..31P NMR
(162 MHz, CD2Cl2): δ 29.34. Anal. Calcd for C41H38NOPNi:
C, 75.71; H, 5.89; N, 2.15. Found: C, 75.76; H, 5.92; N, 2.19.
2-(2-ter t-Bu t yl-6-m et h yla n ilin o)t r op on e Ni Com p lex
3d . The general procedure was employed with 219 mg (0.59
mmol) of the sodium salt and 409 mg (0.59 mmol) of (Ph3P)2-
Ni(Ph)(Cl) to afford 185 mg (47%) of the desired complex as a
1
yellow-orange solid. H NMR (400 MHz, C6D6): δ 7.63 (m, 6
H), 7.23 (bs, 1 H), 7.15 (m, 1 H), 6.98 (m, 10 H), 6.81 (m, 2 H),
6.75 (d, J ) 10.4 Hz, 1 H), 6.58 (at, J ) 10 Hz, 1 H), 6.48 (m,
2 H), 6.41 (m, 3 H), 6.11 (at, J ) 9.0 Hz, 1 H), 2.46 (s, 3 H),
1.69 (s, 9 H). 13C NMR (100 MHz, CD2Cl2): δ 179.8 (d, J ) 7.3
Hz), 168.1, 149.3 (d, J ) 45.3 Hz), 145.6, 142.1, 138.3 (broad),
137.2 (broad), 134.7, 134.5 (d, J ) 10.5 Hz), 133.9, 133.1, 131.9,
131.4, 130.1, 128.2 (d, J ) 9.9 Hz), 128.1, 127.1, 124.9 (broad),
124.4, 121.7, 121.1, 120.4, 119.7, 36.9, 33.3, 19.6..31P NMR (162
MHz, CD2Cl2): δ 29.02. Anal. Calcd for C42H40NOPNi: C,
75.92; H, 6.07; N, 2.11. Found: C, 75.75; H, 6.11; N, 2.15.
2-(2,6-Dip h en yla n ilin o)tr op on e Ni Com p lex 3e. The
general procedure was employed with 225 mg (0.55 mmol) of
the sodium salt and 380 mg (0.55 mmol) of (Ph3P)2Ni(Ph)(Cl)
to afford 220 mg (54%) of the desired complex as a yellow-
orange solid. The compound was isolated with 0.33 equiv of
Gen er a l P r oced u r e for t h e Syn t h esis of 2-An ili-
n otr op on e Nick el Com p lexes (3). In a flame-dried Schlenk
flask in a glovebox were added the sodium salt of 2-anili-
notropone-THF (1.0 equiv) and (Ph3P)2Ni(Ph)(Cl) (1.0 equiv).
The flask was removed from the glovebox, placed on a vacuum
line under Ar, and cooled to -30 °C in a dry ice/acetone bath.
THF (∼15 mL) was added to the flask, which was warmed to
room temperature for 1 h. The reaction mixture was stirred
at ambient temperature for 1 h. THF was removed in vacuo,
and the crude reaction mixture was dissolved in toluene (∼15
mL). Cannula transfer onto a pad of Celite was followed by
filtration under argon. The Celite pad was washed with toluene
(3 × 5 mL), and the solvent volume was reduced to 3-5 mL.
Pentane (50 mL) was added, and the Schlenk flask was placed
in a -30 °C freezer overnight. Solvent was removed from the
precipitate via cannula filtration, and the residual solid was
washed with pentane (3 × 10 mL). Drying in vacuo produces
the desired nickel complex.
2-(2,6-Dim eth yla n ilin o)tr op on e Ni Com p lex 3a . The
general procedure was employed with 172 mg (0.54 mmol) of
the sodium salt and 372 mg (0.54 mmol) of (Ph3P)2Ni(Ph)(Cl)
to afford 190 mg (57%) of the desired complex as a yellow-
orange solid. 1H NMR (400 MHz, CD2Cl2): δ 7.54 (m, 6 H),
7.39 (m, 3 H), 7.28 (m, 6 H), 7.21 (d, J ) 8 Hz, 2 H), 7.09 (dd,
J ) 10, 10.6 Hz, 1 H), 6.99 (m, 2 H), 6.94 (d, J ) 10.6 Hz, 1
H), 6.71 (d, J ) 10.7 Hz, 1 H), 6.63 (at, J ) 9.5 Hz, 1 H), 6.56
(t, J ) 8 Hz, 1 H), 6.22 (m, 2 H), 6.14 (m, 2 H), 2.21 (s, 6 H).
13C NMR (100 MHz, CD2Cl2): δ 179.9 (d, J ) 7.2 Hz), 167.7,
150.3 (d, J ) 44.5 Hz), 146.4, 136.9 (d, J ) 1.8 Hz), 134.7,
134.6 (d, J ) 10.7 Hz), 134.3, 131.8 (d, J ) 1.9 Hz), 131.4,
130.1, 128.2 (d, J ) 9.7 Hz), 127.7, 124.8 (d, J ) 2.6 Hz), 124.3,
122.0, 121.1, 120.5, 117.7, 18.3.31P NMR (162 MHz, C6D6): δ
29.03. Anal. Calcd for C39H34NOPNi: C, 75.26; H, 5.51; N, 2.25.
Found: C, 75.49; H, 5.57; N, 2.38.
1
toluene. H NMR (400 MHz, C6D6): δ 7.95 (d, J ) 7.6 Hz, 4
H), 7.49 (m, 6 H), 7.20 (m, 6 H), 7.13 (m, 6 H), 6.98 (8 H +
toluene), 6.77 (d, J ) 11.6 Hz, 1 H), 6.55 (m, 2 H), 6.4 (m, 4
H), 6.02 (m, 1 H), 2.09 (toluene). 13C NMR (100 MHz, CD2-
Cl2): δ 179.6 (d, J ) 7.5 Hz), 168.9, 148.0 (d, J ) 45.1 Hz),
144.6, 140.8, 138.3 (d, J ) 2.7 Hz), 137.0, 134.8, 134.5 (d, J )
10.6 Hz), 133.8, 131.8, 131.3, 130.5, 130.2, 130.0 (d, J ) 1.9
Hz), 129.3, 128.5, 128.1 (d, J ) 9.8 Hz), 127.7, 127.0, 125.6,
125.2, 124.9 (d, 1.9 Hz), 122.0, 121.2, 121.1, 120.5, 21.5..31
P
NMR (162 MHz, C6D6): δ 29.03. Anal. Calcd for C49H38NOPNi‚
0.33(toluene): C, 79.3; H, 5.27; N, 1.80. Found: C, 79.24; H,
5.37; N, 1.77.
2-(2,6-Dich lor oa n ilin o)tr op on e Ni Com p lex 3f. The
general procedure was employed with 200 mg (0.50 mmol) of
the sodium salt and 344 mg (0.50 mmol) of (Ph3P)2Ni(Ph)(Cl)
to afford 250 mg (75%) of the desired complex as a yellow-
1
orange solid. H NMR (400 MHz, C6D6): δ 7.54 (m, 6 H), 7.39
(m, 3 H), 7.29 (m, 6 H), 7.09 (dt, J ) 1.0, 10.2 Hz, 1 H), 6.96
(m, 5 H), 6.72 (d, J ) 10.8 Hz, 1 H), 6.70 (d, J ) 8.1 Hz, 1 H),
6.63 (at, J ) 9.5 Hz, 1 H), 6.23 (at, J ) 9.5 Hz, 1 H), 6.23 (m,
2 H), 6.14 (m, 2 H). 13C NMR (100 MHz, CD2Cl2): δ 180.2 (d,
J ) 6.8 Hz), 167.7, 149.9 (d, J ) 45.3 Hz), 144.2, 137.1 (d, J )
1.7 Hz), 135.5, 134.8, 134.7 (d, J ) 10.6 Hz), 131.7, 131.3, 130.2
(d, J ) 2 Hz), 128.2 (d, J ) 9.7 Hz), 128.1, 125.6, 124.9 (d, J
) 2.1 Hz), 123.2, 122.9, 121.4, 117.8. 31P NMR (162 MHz, CD2-
Cl2): δ 29.13. Anal. Calcd for C37H28NOPNiCl2: C, 67.00; H,
4.26; N, 2.11. Found: C, 66.95; H, 4.37; N, 2.15.
2-(2,6-Dibr om oa n ilin o)tr op on e Ni Com p lex 3g. The
general procedure was employed with 220 mg (0.49 mmol) of
the sodium salt and 341 mg (0.49 mmol) of (Ph3P)2Ni(Ph)(Cl)
to afford 315 mg (85%) of the desired complex as a yellow-
orange solid. 1H NMR (400 MHz, CD2Cl2): δ 7.54 (m, 6 H),
7.39 (m, 3 H), 7.28 (m, 6 H), 7.21 (d, J ) 8.0 Hz, 2 H), 7.09 (m,
1 H), 7.00 (m, 2 H), 6.94 (d, J ) 10.4 Hz, 1 H), 6.72 (d, J )
10.8 Hz, 1 H), 6.63 (at, J ) 9.4 Hz, 1 H), 6.56 (t, J ) 8.0 Hz,
1 H), 6.22 (m, 2 H), 6.14 (t, J ) 7.2 Hz, 2 H). 13C NMR (100
MHz, CD2Cl2): δ 180.2 (d, J ) 6.8 Hz), 167.3, 149.6 (d, J )
45.7 Hz), 146.5, 137.4, 135.5, 134.8, 134.7 (d, J ) 10.6 Hz),
2-(2,6-Diisop r op yla n ilin o)tr op on e Ni Com p lex 3b. The
general procedure was employed with 201 mg (0.54 mmol) of
the sodium salt and 372 mg (0.54 mmol) of (Ph3P)2Ni(Ph)(Cl)
to afford 241 mg (67%) of the desired complex as a yellow-
1
orange solid. H NMR (400 MHz, C6D6): δ 7.63 (m, 6 H), 7.08
(d, J ) 7.0 Hz, 2 H), 6.98 (m, 12 H), 6.76 (d, J ) 10.4 Hz, 1 H),
6.58 (at, J ) 9.9 Hz, 1 H). 6.53 (d, J ) 11.5 Hz, 1 H), 6.45-
6.33 (m, 4 H), 6.13 (at, J ) 9.4 Hz, 1 H), 3.82 (sept, J ) 6.8
Hz, 2 H), 1.32 (d, J ) 6.8 Hz, 6 H), 1.09 (d, J ) 6.8 Hz, 6 H).
13C NMR (100 MHz, C6D6): δ 180.2 (d, J ) 7.6 Hz), 169.6,
148.9 (d, J ) 45 Hz), 144.4, 142.3, 138.1 (d, J ) 2.2 Hz), 134.6
(d, J ) 10.5 Hz), 133.1, 132.0, 131.6, 129.9 (d, J ) 1.9 Hz),
125.9, 125.5 (d, J ) 2 Hz), 123.7, 122.2, 121.7, 121.3, 121.1,
29.0, 25.9, 23.9. 31P NMR (162 MHz, C6D6): δ 28.9. Anal. Calcd
for C43H42NOPNi: C, 76.12; H, 6.24; N, 2.06. Found: C, 75.83;
H, 6.24; N, 1.98.
2-(2-ter t-Bu t yla n ilin o)t r op on e Ni Com p lex 3c. The
general procedure was employed with 201 mg (0.53 mmol) of
the sodium salt and 372 mg (0.54 mmol) of (Ph3P)2Ni(Ph)(Cl)